Detalhe da pesquisa
1.
Cholecystohepatic shunt pathway reduces secondary bile acid accumulation to enhance natural killer T cell-mediated anti-hepatocellular carcinoma immunity.
J Gastroenterol Hepatol;
2024 May 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38747068
2.
Castleman Disease Misdiagnosed as Pancreatic Neuroendocrine Tumor by Fine Needle Aspiration Biopsy.
Am Surg;
89(6): 2979-2981, 2023 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35544955
3.
A Case of Insidious Onset of Kimura Disease-associated Immunoglobulin A Nephropathy without Eosinophil Infiltration in the Renal Tissue.
Iran J Allergy Asthma Immunol;
22(6): 604-608, 2023 Dec 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38477957
4.
Castleman disease of the pancreas mimicking pancreatic malignancy on 68Ga-DOTATATE and 18F-fluorodeoxyglucose positron emission tomography/computed tomography: A case report.
World J Gastrointest Surg;
14(5): 514-520, 2022 May 27.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35734619
5.
Effectiveness of radiofrequency ablation versus transarterial chemoembolization for recurrent hepatocellular carcinoma: A meta-analysis.
Acta Radiol Open;
11(3): 20584601221085514, 2022 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35368406
6.
Obeticholic acid and 5ß-cholanic acid 3 exhibit anti-tumor effects on liver cancer through CXCL16/CXCR6 pathway.
Front Immunol;
13: 1095915, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36605219